Vertex Pharmaceuticals (VRTX) Shares Outstanding (2009 - 2026)

Vertex Pharmaceuticals' Shares Outstanding (Entity) history runs 18 years deep, the most recent figure standing at $254.2 million for Q1 2026.

• On a quarterly basis, Shares Outstanding (Entity) fell 1.09% year-over-year to $254.2 million in Q1 2026; TTM through Mar 2026 was $254.2 million, a 1.09% decrease from a year earlier, with the FY2025 full-year figure at $254.0 million, down 1.15% from the prior year.
• Shares Outstanding (Entity) held at $254.2 million in Q1 2026 per VRTX's latest filing, from $254.0 million in the prior quarter.
• Across five years, Shares Outstanding (Entity) topped out at $258.3 million in Q1 2024 and bottomed at $254.0 million in Q3 2025.
• The 5-year median for Shares Outstanding (Entity) is $257.0 million (2025), against an average of $256.6 million.
• Across the five-year window, Shares Outstanding (Entity) increased 1.0% in 2022 and declined 1.47% in 2025, its largest moves.
• Year by year, Shares Outstanding (Entity) stood at $257.0 million in 2022, then grew by 0.27% to $257.7 million in 2023, then decreased by 0.29% to $256.9 million in 2024, then fell by 1.15% to $254.0 million in 2025, then climbed by 0.07% to $254.2 million in 2026.
• Per Business Quant, the three latest VRTX Shares Outstanding (Entity) figures stand at $254.2 million (Q1 2026), $254.0 million (Q4 2025), and $254.0 million (Q3 2025).